Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Terminated Phase 1 Trials for Decitabine (DB01262)

IndicationStatusPhase
DBCOND0029236 (Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00049582Decitabine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid LeukemiaTreatment